2025
WiCell has expanded its stem cell repository with six new LQT Interval Cardiac Trait Cell Lines. Developed by Dr. Kelly Frazer at UC San Diego, these CRISPR-edited iPSC lines help researchers study Long QT Syndrome, advancing drug discovery and gene therapy. Read the full details in the press release and explore the new cell lines in our catalog.
WiCell is proud to announce the grand opening of our new cGMP laboratory space. This state-of-the-art facility was designed to meet the growing demand for high-quality cell characterization and testing services. Read more about how this new space enhances our ability to deliver regulatory-compliant solutions and support your research.
2024
WiCell has added two new flow cytometry-based assays—Undifferentiated Status and Assesment of Pluripotency Assays—to its suite of cell characterization services. These assays provide precise, quantitative tools for verifying stem cell integrity, aiding researchers in stem cell biology, drug discovery, and regenerative medicine. Read the full press release for additional details.
Combat cell line misidentification and ensure accurate, reliable research outcomes with WiCell's new cGMP STR Profiling Service. This industry-standard tool is essential for stem cell research, regenerative medicine, and cell and gene therapy. Discover the benefits and learn more in the full press release.
WiCell enhances its website with the the addition of the Bioz Content Hub, empowering researchers to make informed decisions. Discover the most effective stem cell lines using publication data and evidence-based ratings. Read more in the press release announcing this new and exciting tool.
WiCell's Dr. Tenneille Ludwig, Senior Scientist and Director of the WiCell Stem Cell Bank has been named as a candidate to the International Society for Stem Cell Research (ISSCR) Board of Directors in the area of industry expertise. Voting begins 15 February, 2024. Read the entire press release and vote!
